Literature DB >> 7633732

A community study of snoring and sleep-disordered breathing. Health outcomes.

L G Olson1, M T King, M J Hensley, N A Saunders.   

Abstract

Four hundred forty-one subjects 34 to 69 yr of age were recruited from a random sample of the community. They answered a questionnaire and were monitored in their homes for sleep-disordered breathing (SDB). This report concerns the association between observed SDB and arterial hypertension and vascular disease. Hypertension was defined as self-report of a diagnosis of hypertension made by a physician, current treatment for hypertension, or a systolic pressure greater than 150 mm Hg or a diastolic pressure greater than 90 mm Hg. Coronary artery disease was defined by self-report of angina or myocardial infarction of "heart attack." There were few cases of stroke or claudication, and a category of "occlusive vascular disease" was defined by self-report of coronary artery disease or of "blocked arteries" or stroke. Subjects were classified as snorers (n = 289) or nonsnorers (n = 73) by self-report of regular snoring, and as having SDB (n = 79) if more than 15 abnormal respiratory events were recorded per hour of recording. There were significant increases in the prevalence of hypertension, coronary artery disease, and occlusive vascular disease from nonsnorers (26, 7, and 10%, respectively) through snorers (39, 12, and 17%) to subjects with SDB (57, 20, and 28%). The crude odds ratio for SDB versus nonsnorers was 3.8 (95% CI, 1.9 to 7.5) for hypertension, 3.5 (1.2 to 10.0) for coronary artery disease, and 3.7 (1.5 to 9.1) for occlusive vascular disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7633732     DOI: 10.1164/ajrccm.152.2.7633732

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

Review 1.  Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

Authors:  D S Silverberg; A Oksenberg
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

3.  Prediction of obstructive sleep apnea syndrome in a large Greek population.

Authors:  Izolde Bouloukaki; Fotis Kapsimalis; Charalampos Mermigkis; Meir Kryger; Nikos Tzanakis; Panagiotis Panagou; Violeta Moniaki; Eleni M Vlachaki; Georgios Varouchakis; Nikolaos M Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2010-09-25       Impact factor: 2.816

4.  The effect of singing on snoring and daytime somnolence.

Authors:  Irumee Pai; Stephen Lo; Dennis Wolf; Azgher Kajieker
Journal:  Sleep Breath       Date:  2008-01-08       Impact factor: 2.816

5.  Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort.

Authors:  Peter Elwood; Melissa Hack; Janet Pickering; Janie Hughes; John Gallacher
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

Review 6.  The epidemiology of sleep apnoea.

Authors:  R J Davies; J R Stradling
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 7.  Respiratory dreams and nightmares.

Authors:  N Douglas
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

8.  Association between Snoring and High-Risk Carotid Plaque Features.

Authors:  Erin M Kirkham; Thomas S Hatsukami; Susan R Heckbert; Jie Sun; Gador Canton; Chun Yuan; Edward M Weaver
Journal:  Otolaryngol Head Neck Surg       Date:  2017-07-11       Impact factor: 3.497

Review 9.  Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.

Authors:  Karl A Franklin; Eva Lindberg
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Sleep quality in middle-aged and elderly Chinese: distribution, associated factors and associations with cardio-metabolic risk factors.

Authors:  Nazanin Haseli-Mashhadi; Tony Dadd; An Pan; Zhijie Yu; Xu Lin; Oscar H Franco
Journal:  BMC Public Health       Date:  2009-05-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.